Details for New Drug Application (NDA): 019832
✉ Email this page to a colleague
NDA 019832 describes SULFAMYLON, which is a drug marketed by Rising and Mylan Institutional and is included in two NDAs. It is available from one supplier. Additional details are available on the SULFAMYLON profile page.
The generic ingredient in SULFAMYLON is mafenide acetate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.
The generic ingredient in SULFAMYLON is mafenide acetate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.
Summary for 019832
| Tradename: | SULFAMYLON |
| Applicant: | Mylan Institutional |
| Ingredient: | mafenide acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019832
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;TOPICAL | Strength | 5% | ||||
| Approval Date: | Jun 5, 1998 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
